RNS System Clinical Trials

Skip to main content
NeuroPace, Inc.
  • Patients
  • Providers
  • Corporate
  • PDMS
  • nSight
  • Take the Quiz
  • Learn About the RNS System
    • Drug-Resistant Epilepsy
    • The RNS System
  • See if you Qualify
    • Take the Quiz
    • Find a Center
  • Hear from Patients
    • Patient Stories
    • How Data Helped
  • Resources
    • Find a Center
    • Education (brochures, infographics, videos)
    • Helpful Links
    • Contact Us
  • Blog
  • Active Clinical Trials
  • Current Patients
    • Manuals
    • MRI Safety
    • How-to Videos
    • Living with the RNS System
    • Current Patient FAQ
  • Learn About the RNS System
    • Drug-Resistant Epilepsy
    • The RNS System
  • See if you Qualify
    • Take the Quiz
    • Find a Center
  • Hear from Patients
    • Patient Stories
    • How Data Helped
  • Resources
    • Find a Center
    • Education (brochures, infographics, videos)
    • Helpful Links
    • Contact Us
  • Blog
  • Active Clinical Trials
  • Current Patients
    • Manuals
    • MRI Safety
    • How-to Videos
    • Living with the RNS System
    • Current Patient FAQ
Press enter to begin your search
Could the RNS System be right for me? Start Quiz

RNS System Clinical Trials

Looking to enroll?

NeuroPace is committed to continuing to improve the lives of people living with epilepsy. Please click on the blue buttons below to learn about these trials and take a short quiz to determine if enrollment may be right for you or your teen.

RESPONSE Study

RNS System clinical study for teens 12 through 17 years of age with focal onset epilepsy

NAUTILUS Study

RNS System clinical study for adults and teens 12 years and older with idiopathic generalized epilepsy

Lennox-Gastaut Syndrome Study

RNS System clinical study for adults and teens 12 years and older with Lennox‑Gastaut Syndrome

Para información en español, haga clic aquí

Further detailed information about these studies for enrolled or prospective patients

The RNS System is investigational for the type of epilepsy and age range described in the studies below. The RNS Neurostimulator Model RNS-320 will be used in each study. For additional information about the investigational Indication for Use and the RNS Neurostimulator Model RNS-320 (product manuals), click on the purple buttons below.

Additional RESPONSE Study Information

Additional NAUTILUS Study Information

Additional Lennox-Gastaut Syndrome Study Information

  • Safety Information
  • Legal
  • Privacy Policy
1-866-726-387624-hr Support Line

PATIENTS

  • Drug-Resistant Epilepsy
  • The RNS System
  • Hear from Patients
  • Is It Right for You?
  • Current Patients
  • Resources

PROVIDERS

  • Product
  • Clinical Benefits
  • Actionable Insights
  • Patient Selection
  • Education & Training
  • Resources

ABOUT US

  • In The News
  • Press Releases
  • Leadership
  • Careers
  • Contact Us
  • FCOI Procedure

  • PATIENTS

    Safety

  • PROVIDERS

    Legal

  • INVESTORS

    Privacy Policy

  • ABOUT US

1-866-726-3876 24-hr Support Line

© 2026 NeuroPace, Inc..

Step 1 of 7

14%
    The RNS System is for individuals 18 and older who have focal epilepsy and have tried two or more medications without finding seizure control.

  • Based on your answers, your patient might benefit from the RNS System.

    Get your profile and a list of questions to ask your doctor.

  • Unfortunately it appears your patient is not an appropriate candidate for the RNS® System at this time.

  • The RNS® System is intended for patients who have undergone diagnostic testing that localized no more than 2 epileptogenic foci.

    If your patient has not undergone diagnostic testing, search here to find a comprehensive epilepsy center that can evaluate your patient, including determining if the RNS System is right for them.

  • If you are interested in learning more about the RNS® System, you can have an RNS® System professional contact you by filling out the form below:

  • By filling out this form, you are agreeing to the terms of our privacy policy. This form is intended for US residents only.

    By clicking submit, you are agreeing to receive communications from NeuroPace. You can unsubscribe at any time.

    * Required fileds

Share your Story: Terms and conditions

By filling out the form and submitting your story (and/or photograph), you are agreeing to the following:

  1. NeuroPace may review the information and any photographs you provide for potential publication on our website.
  2. If NeuroPace decides to use your story, we will contact you and ask you to sign a release for a version of your story to be used on the NeuroPace website, Facebook, Instagram, Twitter and/or LinkedIn. Unless you sign the release, we will not publish the story, your name, or the photographs you provided.
  3. Regardless of whether we publish your story, we will add your name and e-mail address to the NeuroPace email list to hear from us about product updates, upcoming events and other relevant information. We will not sell your information to third parties. 
  4. Our use of your information is subject to our Privacy Policy, which you can access here.
neuropace logoLogo Header Menu
  • Patients
  • Providers
  • Corporate
  • PDMS
  • nSight
  • Take the Quiz